Literature DB >> 25138153

In vivo over-expression of KGF mimic human middle ear cholesteatoma.

Tomomi Yamamoto-Fukuda1, Naotaro Akiyama, Yasuaki Shibata, Haruo Takahashi, Tohru Ikeda, Takehiko Koji.   

Abstract

We reported previously that keratinocyte growth factor (KGF), a mesenchymal cell-derived paracrine growth factor, plays an important role in middle ear cholesteatoma formation, which is characterized by marked proliferation of epithelial cells. Here, we investigated whether KGF, the main factor that induces cholesteatoma, overexpression in vivo results in the formation of cholesteatoma. Flag-hKGF cDNA driven by CMV14 promoter was transfected through electroporation into the external auditory canal (EAC) of rats once (short-term model) or five times on every fourth day (long-term model). Ears transfected with empty vector were used as controls. Successful transfection of plasmids into epithelial and stromal cells was confirmed by Flag immunohistochemistry. In the short-term model, the intensity of KGF protein was the strongest in hKGF transfected ear at day 4. KGF expression induced epithelial cell proliferation, reaching a peak level at day 4 and then decreased later, while in the long-term model, KGF expression in the EAC led to middle ear cholesteatoma formation. In conclusion, we described here a new experimental model of human middle ear cholesteatoma, and demonstrated that KGF and KGF receptor paracrine action play an essential role in middle ear cholesteatoma formation in an in vivo model.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25138153     DOI: 10.1007/s00405-014-3237-6

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  31 in total

1.  Expression patterns of cytokeratins in retraction pocket cholesteatomas.

Authors:  H J Kim; S P Tinling; R A Chole
Journal:  Laryngoscope       Date:  2001-06       Impact factor: 3.325

2.  Incidence, etiology and pathogenesis of cholesteatoma in children.

Authors:  M Tos
Journal:  Adv Otorhinolaryngol       Date:  1988

3.  Pathogenesis and surgical treatment of the middle ear cholesteatoma.

Authors:  L Rüedi
Journal:  Acta Otolaryngol Suppl       Date:  1979

4.  Large induction of keratinocyte growth factor expression by serum growth factors and pro-inflammatory cytokines in cultured fibroblasts.

Authors:  M Brauchle; K Angermeyer; G Hübner; S Werner
Journal:  Oncogene       Date:  1994-11       Impact factor: 9.867

5.  Keratinocyte growth factor induces hyperproliferation and delays differentiation in a skin equivalent model system.

Authors:  S T Andreadis; K E Hamoen; M L Yarmush; J R Morgan
Journal:  FASEB J       Date:  2001-04       Impact factor: 5.191

6.  Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth.

Authors:  P W Finch; J S Rubin; T Miki; D Ron; S A Aaronson
Journal:  Science       Date:  1989-08-18       Impact factor: 47.728

7.  Expression of a cell-cycle-associated nuclear antigen (MIB 1) in cholesteatoma and auditory meatal skin.

Authors:  H Sudhoff; J Bujía; A Fisseler-Eckhoff; A Holly; C Schulz-Flake; H Hildmann
Journal:  Laryngoscope       Date:  1995-11       Impact factor: 3.325

8.  Possible autocrine growth stimulation of cholesteatoma epithelium by transforming growth factor alpha.

Authors:  P Schulz; J Bujía; A Holly; V Shilling; E Kastenbauer
Journal:  Am J Otolaryngol       Date:  1993 Mar-Apr       Impact factor: 1.808

Review 9.  Surgical techniques and recidivism in cholesteatoma.

Authors:  D R Edelstein; S C Parisier
Journal:  Otolaryngol Clin North Am       Date:  1989-10       Impact factor: 3.346

10.  Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesenchymal-epithelial interactions.

Authors:  P W Finch; G R Cunha; J S Rubin; J Wong; D Ron
Journal:  Dev Dyn       Date:  1995-06       Impact factor: 3.780

View more
  8 in total

1.  Regulation of DNA methylation levels in the process of oral mucosal regeneration in a rat oral ulcer model.

Authors:  Naotaro Akiyama; Tomomi Yamamoto-Fukuda; Mamoru Yoshikawa; Hiromi Kojima
Journal:  Histol Histopathol       Date:  2019-07-09       Impact factor: 2.303

2.  Analysis of the epidermal growth factor receptor/phosphoinositide-dependent protein kinase-1 axis in tumor of the external auditory canal in response to epidermal growth factor stimulation.

Authors:  Naotaro Akiyama; Tomomi Yamamoto-Fukuda; Mamoru Yoshikawa; Hiromi Kojima
Journal:  Laryngoscope Investig Otolaryngol       Date:  2022-03-30

3.  Keratinocyte Growth Factor (KGF) Modulates Epidermal Progenitor Cell Kinetics through Activation of p63 in Middle Ear Cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Naotaro Akiyama; Masahiro Takahashi; Hiromi Kojima
Journal:  J Assoc Res Otolaryngol       Date:  2018-03-16

4.  Intercellular Communication between Keratinocytes and Fibroblasts Induces Local Osteoclast Differentiation: a Mechanism Underlying Cholesteatoma-Induced Bone Destruction.

Authors:  Yoriko Iwamoto; Keizo Nishikawa; Ryusuke Imai; Masayuki Furuya; Maki Uenaka; Yumi Ohta; Tetsuo Morihana; Saori Itoi-Ochi; Josef M Penninger; Ichiro Katayama; Hidenori Inohara; Masaru Ishii
Journal:  Mol Cell Biol       Date:  2016-05-16       Impact factor: 4.272

5.  Super-enhancer Acquisition Drives FOXC2 Expression in Middle Ear Cholesteatoma.

Authors:  Tomomi Yamamoto-Fukuda; Naotaro Akiyama; Hiromi Kojima
Journal:  J Assoc Res Otolaryngol       Date:  2021-04-16

6.  Stem cells in middle ear cholesteatoma contribute to its pathogenesis.

Authors:  Julia Nagel; Saskia Wöllner; Matthias Schürmann; Viktoria Brotzmann; Janine Müller; Johannes Fw Greiner; Peter Goon; Barbara Kaltschmidt; Christian Kaltschmidt; Holger Sudhoff
Journal:  Sci Rep       Date:  2018-04-18       Impact factor: 4.379

7.  Chronic inflammation of middle ear cholesteatoma promotes its recurrence via a paracrine mechanism.

Authors:  Matthias Schürmann; Felix Oppel; Senyao Shao; Verena Volland-Thurn; Christian Kaltschmidt; Barbara Kaltschmidt; Lars-Uwe Scholtz; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2021-02-24       Impact factor: 5.712

Review 8.  Review of potential medical treatments for middle ear cholesteatoma.

Authors:  Matthias Schürmann; Peter Goon; Holger Sudhoff
Journal:  Cell Commun Signal       Date:  2022-09-19       Impact factor: 7.525

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.